France Cataract Surgery Devices Market Size, Share, By Product (Phacoemulsification Systems, Femtosecond Laser Systems, Ophthalmic Viscoelastic Devices, Intraocular Lenses, and Others), By Technique (Phacoemulsification, Manual Small-Incision Cataract Surgery (MSICS), Femtosecond Laser-Assisted Cataract Surgery (FLACS), and Others), By Comorbidity (With Comorbidities and Without Comorbidities), By End Use (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers (ASCs), and Others), and France Cataract Surgery Devices Market Insights, Industry Trend, Forecasts to 2035

France Cataract Surgery Devices Market Size Insights Forecasts to 2035

• France Cataract Surgery Devices Market Size 2024: USD 239.8 Mn
• France Cataract Surgery Devices Market Size 2035:  USD 454.2 Mn
• France Cataract Surgery Devices Market CAGR 2024: 5.98%
• France Cataract Surgery Devices Market Segments: Product, Technique, Comorbidity, and End Use

The France Cataract Surgery Devices Market Size is a segment of the medical devices industry that involves the creation, production, and utilization of the instruments and technologies that are used to diagnose and treat cataracts surgically, cataract removal, and vision restoration, such as intraocular lenses, phacoemulsification systems, and ophthalmic surgical instruments in France. The market covers the usage of intraocular lenses (IOLs), phacoemulsification systems, ophthalmic surgical instruments, viscoelastic devices, and other consumables that help in performing safe and effective cataract procedures in hospitals and ophthalmic clinics across the country.

France appears to be a promising market for cataract surgery devices based on the health needs of its population. A significant 20.7% of the total population in France constitutes individuals aged 65 years and above, with cataracts being one of the major causes of vision loss in this age group. The data reveal that over 60% of people over 70 years of age have a cataract of some kind, which leads to more than 1 million cataract surgeries being conducted annually in France. The high prevalence of the disease, aging demographic, and large surgical volume collectively underscore the urgent demand and the vital role of cataract surgery devices in the restoration of vision and improvement of the quality of life of the French population.

The France Cataract Surgery Devices Market Size will continue to grow with the increased demand for surgery driven by the aging population. Hospitals and ophthalmic clinics have a strong focus on improving outcomes, and thus they are rapidly adopting advanced phacoemulsification systems and premium intraocular lenses. There are new possibilities in the area of minimally invasive technologies and outpatient surgical care made possible by the government support through well-known programs such as the Health Innovation Plan 2030, which commits close to €7.5 billion to healthcare innovation, thus further facilitating the ongoing adoption and research in the area of cataract surgery devices.

Market Dynamics of the France Cataract Surgery Devices Market:

The France Cataract Surgery Devices Market Size is driven by the growth of an aging population and an increase in the prevalence of cataracts. As a result of technological advancements in phacoemulsification systems and premium intraocular lenses, surgical efficiency and outcomes have significantly improved. Additionally, the presence of a well-developed healthcare infrastructure and the availability of reimbursement support have been instrumental in further encouraging the adoption of procedures.

The France Cataract Surgery Devices Market Size faces limitations due to the expensive advanced and premium intraocular lenses that can make patient adoption difficult. The market expansion is also impacted by strict regulatory approval procedures and pricing pressures resulting from reimbursement policies. Besides that, reliance on publicly funded healthcare may delay the adoption of new technologies.

The France Cataract Surgery Devices Market Size presents strong future opportunities through advancements in premium intraocular lenses and laser-assisted cataract surgery technologies. Innovations in imaging, surgical guidance, and minimally invasive procedures are helping to improve both outcomes and efficiency. The increasing number of outpatient surgical centers and growing patient awareness will thus become additional factors contributing to the market development.

Market Segmentation

The France Cataract Surgery Devices Market share is classified into product, technique, comorbidity, and end use.

By Product:

The France Cataract Surgery Devices Market Size is divided by product into phacoemulsification systems, femtosecond laser systems, ophthalmic viscoelastic devices, intraocular lenses, and others. Among these, the intraocular lenses segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The intraocular lenses segment dominates because of the high volume of cataract surgeries requiring IOL implantation as a standard procedure. Growing adoption of premium IOLs, such as multifocal and toric lenses, for improved visual outcomes and reduced dependence on spectacles further drives the segment’s strong market share and growth.

By Technique:

The France Cataract Surgery Devices Market Size is divided by technique into phacoemulsification, manual small-incision cataract surgery (MSICS), femtosecond laser-assisted cataract surgery (FLACS), and others. Among these, the phacoemulsification segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The phacoemulsification segmental dominance is due to its high success rate, minimal invasiveness, faster recovery time, and wide acceptance among ophthalmic surgeons. Its compatibility with advanced intraocular lenses and strong reimbursement support in France further contribute to its continued dominance and growth.

By Comorbidity:

The France Cataract Surgery Devices Market Size is divided by comorbidity into with comorbidities and without comorbidities. Among these, the without comorbidities segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The without comorbidities segment dominance is due to lower surgical risk, fewer complications, and faster postoperative recovery in otherwise healthy patients. These patients are more likely to undergo elective cataract surgery earlier, driving higher procedure volumes and continued segment growth.

By End Use:

The France Cataract Surgery Devices Market Size is divided by end use into hospitals, ophthalmic clinics, ambulatory surgical centers (ASCs), and others. Among these, the hospitals segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The hospital’s segmental growth is due to the high volume of cataract surgeries, the availability of advanced ophthalmic surgical infrastructure, and the presence of skilled ophthalmologists. Strong reimbursement support and the ability to manage complex and high-risk cases further drive the continued growth of hospital-based cataract procedures.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the France Cataract Surgery Devices Market Size, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Top Key Companies in France Cataract Surgery Devices Market:

• Alcon, Inc.
• Johnson & Johnson Vision
• Bausch + Lomb, Inc.
• Carl Zeiss Meditec AG
• EssilorLuxottica SA
• Topcon Corporation
• STAAR Surgical Company
• Abbott Laboratories
• Hoya Corporation
• Nidek Co., Ltd.
• PhysIOL S.A.
• Rayner Intraocular Lenses Limited
• Others

Recent Developments in France Cataract Surgery Devices Market:

• In June 2025, Johnson & Johnson Vision launched its next-generation TECNIS Odyssey intraocular lens in Europe, offering cataract patients continuous clear vision across all distances and expanded options for advanced cataract care in the France Cataract Surgery Devices Market Size.

• In April 2025, Alcon announced the European launch of its UNITY Vitreoretinal and UNITY Cataract Systems, enhancing surgical efficiency and outcomes and supporting advanced cataract care in the France Cataract Surgery Devices Market Size.

• In December 2025, French intraocular lens manufacturer Cristalens Industrie unveiled a new innovative IOL molding project at its Lannion facility, backed by a €500,000 France 2030 repayable advance to boost local cataract device manufacturing and capacity.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France Cataract Surgery Devices Market Size based on the below-mentioned segments:

France Cataract Surgery Devices Market, By Product  

• Phacoemulsification Systems
• Femtosecond Laser Systems
• Ophthalmic Viscoelastic Devices
• Intraocular Lenses
• Others

France Cataract Surgery Devices Market, By Technique

• Phacoemulsification
• Manual Small-Incision Cataract Surgery (MSICS)
• Femtosecond Laser-Assisted Cataract Surgery (FLACS)
• Others

France Cataract Surgery Devices Market, By Comorbidity

• With Comorbidities
• Without Comorbidities

France Cataract Surgery Devices Market, By End Use

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers (ASCs)
• Others